Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata

January 2017 in “ Pediatric dermatology ”

Mustafa Özdemır, Ali Balevi

Studysummary This study found that 1% anthralin ointment effectively promoted hair growth in children with chronic, severe alopecia areata, showing complete or partial responses in 70% of participants over 12 months, without serious adverse events. Our plain-language summary of this paper — not a Tressless recommendation.

In a 2017 study involving 30 children with chronic, severe, treatment-refractory, extensive alopecia areata (AA), 1% anthralin ointment was applied to one side of the scalp for 12 months, with the other side left untreated. The Severity of Alopecia Tool (SALT) score was used to assess outcomes. Results showed that the mean time to first response was 3 months, and to maximal response was 9 months. After one year, 10 patients (33.4%) achieved complete response, and 11 patients (36.6%) had a partial response, with 6 of the partial responders eventually achieving complete response. No serious adverse events were reported, indicating that 1% anthralin is an effective and safe therapy for AA in children. The study recommended continuing treatment for at least 9 months, and for those with at least a 50% reduction in pretreatment SALT scores, to continue for at least 1 year.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

10 / 10 results

research Efficacy and Safety of Methotrexate in Alopecia Areata

44 citations , August 2014 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia”

This study found that methotrexate may be an effective and safe treatment option for severe alopecia areata, with better regrowth results when combined with corticosteroids.

research Alopecia Areata: An Evidence-Based Treatment Update

72 citations , July 2014 in “American journal of clinical dermatology”

This review analyzed randomized controlled trials on alopecia areata treatment and found that while several treatments showed effectiveness, most studies had limitations affecting their interpretability.

research Current Treatment of Alopecia Areata

71 citations , December 2013 in “The journal of investigative dermatology. Symposium proceedings/The Journal of investigative dermatology symposium proceedings”

This review discusses various treatments for alopecia areata, highlighting their limitations and individualized approach, and reports no new clinical results.

research Advances in the Management of Alopecia Areata

51 citations , December 2011 in “The Journal of Dermatology”

This review discusses updated treatment guidelines for alopecia areata in Japan, highlighting new options like corticosteroid pulse therapy, but reports no new clinical results.

research Investigative Guidelines for Alopecia Areata

66 citations , May 2011 in “Dermatologic therapy”

This report discusses guidelines for designing alopecia clinical trials that account for variables affecting results, but it presents no new efficacy findings.

research Bilateral Treatment for Alopecia Areata

9 citations , July 2010 in “Pediatric dermatology”

In this case study, a 4-year-old girl with alopecia areata showed hair regrowth only on the side treated with corticosteroids, not the side treated with anthralin.

research Alopecia Areata Update

244 citations , January 2010 in “Journal of the American Academy of Dermatology”

This review discusses treatment options for alopecia areata and suggests tailored treatment plans, noting the challenges posed by spontaneous remission and limited high-quality clinical trials.

research Efficacy And Safety Of A New Clobetasol Propionate 0.05% Foam In Alopecia Areata: A Randomized, Double-Blind Placebo-Controlled Trial

114 citations , October 2006 in “Journal of the European Academy of Dermatology and Venereology”

In this study, clobetasol propionate foam demonstrated effectiveness and good patient compliance as a safe topical treatment for moderate to severe alopecia areata, with significant hair regrowth compared to placebo.

research Evaluation of Anthralin in the Treatment of Alopecia Areata

109 citations , November 1987 in “Archives of dermatology”

In this study, 0.5%-1.0% anthralin cream led to a cosmetic response in 25% of patients with severe alopecia areata, despite common side effects like pruritus and erythema.

research A Trial of 1% Minoxidil Used Topically for Severe Alopecia Areata

37 citations , March 1986 in “Acta Dermato Venereologica”

In this study, there was no significant difference in hair growth between patients with extensive alopecia areata treated with 1% minoxidil and those receiving a placebo.